In Finland, the research & development by business enterprise, pharmaceutical industry in current ppp $ stands at 230.89 million, reflecting an increase of 14.71 million (6.8%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Finland
No matching regions
Similar regions to Finland
Business R&D pharmaceutical in current PPP $
More indicators for Finland
Government R&D in security as % of government support
2.13%
+0.15%
(2021)
Higher-education-finacing R&D financed by general university in local currency
7,358.96M
-629.04M
(2021)
R&D financed by rest of the world in local currency
10,499.15M
+729.15M
(2021)
Government R&D financed by rest of the world in local currency
927.92M
+41.92M
(2021)
Business R&D financed by rest of the world in local currency
7,201.34M
+403.34M
(2021)
Non-profit R&D growth rate
-12.04%
-11.84%
(2022)
Finland Business R&D pharmaceutical in current PPP $ between 2008 and 2021
Period | Business R&D pharmaceutical in current PPP $ | Change |
---|---|---|
2021 | 230.89M | +14.71M |
2020 | 216.18M | +21.30M |
2019 | 194.88M | +20.13M |
2018 | 174.76M | +3.86M |
2017 | 170.90M | +8.00M |
2016 | 162.90M | +19.69M |
2015 | 143.21M | -5.27M |
2014 | 148.48M | +16.04M |
2013 | 132.43M | -17.72M |
2012 | 150.15M | +20.07M |
2011 | 130.07M | +13.18M |
2010 | 116.90M | -4.99M |
2009 | 121.89M | -0.12M |
2008 | 122.01M |